Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06756607 · ClinicalTrials.gov registry record · NA

The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials

A NA study of Cancer, sponsored by Eastern Cooperative Oncology Group.

Recruiting
Registry status
NA
Development phase
500
Enrollment target
1
Study location

NCT06756607 is a NA study of Cancer that is actively recruiting participants, run by Eastern Cooperative Oncology Group. The registered enrollment target is 500 participants, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06756607, a NA study of Cancer, is actively recruiting participants, sponsored by Eastern Cooperative Oncology Group.

RECRUITING
Registry status
NA
Development phase
500 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to conduct a Hybrid Type 1 cluster-randomized, roll-out effectiveness-implementation trial in NCORP community oncology practice sites (N= 500 Black and Latino cancer patients) to evaluate the effectiveness of the EA SUPPORT intervention combining CT navigators and CT research literacy tools in improving Black and Latino patient referral and accrual to NCI-supported CTs (primary outcomes) and participant and provider awareness and knowledge of CTs (secondary outcomes) while assessing implementation factors. Also, with the CUSP2CT data, Evaluation, and Coordinating Center, conduct final site evaluation and disseminate the SUPPORT intervention to NCORP community oncology sites, research bases, and affiliated trial networks.

Conditions Studied

Interventions

  • OTHER SUPPORT toolkit

Study Locations (1)

Illinois

  • Northwestern University - Chicago

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2025-04-25
Est. Completion 2029-08-01
Phase NA

Sponsor

Eastern Cooperative Oncology Group

141 total trials

What the Registry Record Tells You About NCT06756607

The ClinicalTrials.gov registry entry for NCT06756607 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (86% lower). The listed sponsor is Eastern Cooperative Oncology Group, which has 141 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which SUPPORT toolkit is the first listed.

NCT06756607 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT06756607 about?

NCT06756607 is a clinical study titled "The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials". The purpose of this study is to conduct a Hybrid Type 1 cluster-randomized, roll-out effectiveness-implementation trial in NCORP community oncology practice sites (N= 500 Black and Latino cancer patients) to evaluate the effectiveness of the EA SUPPORT intervention combining CT navigators and CT res...

What is the current status of trial NCT06756607?

This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2025-04-25. Estimated completion is 2029-08-01.

What conditions does trial NCT06756607 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT06756607?

The interventions under investigation include: SUPPORT toolkit (OTHER).

Who is sponsoring clinical trial NCT06756607?

This trial is sponsored by Eastern Cooperative Oncology Group, which has 141 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06756607 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.